Baseline blood cell percentages were obtained via flow cytometry and showed that lung cancer patients and healthy volunteers did not differ in the baseline percentage of CD4+ cells, CD8+ cells, nor platelets in whole blood (Table 1). This evidence concerns the gene CD4 and lung carcinoma.